RC
RadCall Procedure Guide
← Procedure Library
Procedure Playbook

SpineJack Vertebral Augmentation

Implantable titanium expandable device placed bilaterally to restore vertebral height before cement filling — superior height restoration compared to balloon kyphoplasty with durable craniocaudal expansion.

Sedation
General / MAC
Bleeding Risk
Low (SIR Cat 2)
Key Risk
Device malposition · Cement leak
Antibiotics
Cefazolin 1g IV (implant)
Follow-up
Upright XR at 1 month
1

Indications & Contraindications

When SpineJack is preferred over kyphoplasty

Indications

  • Acute osteoporotic VCF with significant height loss (>30%) โ€” VADs (including SpineJack) emerged specifically for cases of significant vertebral height loss where balloon kyphoplasty is inadequate
  • Young patients where durable height restoration is desired โ€” titanium implant remains in situ indefinitely; balloon kyphoplasty deflates before cement, allowing partial height recollapse
  • Traumatic fractures โ€” SpineJack indicated for compression fractures from osteoporotic, traumatic, and tumor-related causes; level range T5โ€“L5
  • Primary or secondary bone tumors โ€” SpineJack can be used with appropriate oncologic indication alongside cementoplasty for tumor stabilization
  • Cases where kyphosis correction is a priority โ€” SpineJack provides up to 40% height gain and significant kyphotic angle reduction (mean 11โ€“24 degrees in published series)

Contraindications

  • Absolute: Retropulsed fragments causing neurologic deficit (surgery) ยท Active spinal infection / osteomyelitis ยท Uncorrectable coagulopathy ยท PMMA allergy
  • Relative: Posterior wall disruption with canal compromise โ€” device expansion may worsen retropulsion ยท Spinal instability requiring surgical fixation ยท Severe osteoporosis with very low bone density (device may not achieve purchase)
  • OsseoFix absolute contraindication note: Retropulsed fragments and dural sac/cord compression are absolute contraindications for OsseoFix โ€” similar caution applies to all VADs

SpineJack vs. Balloon Kyphoplasty โ€” Key Advantages

  • Durable height restoration: SpineJack remains in situ permanently โ€” balloon deflation before cement in kyphoplasty allows partial cavity collapse; SpineJack maintains full expansion
  • Mechanical (not hydraulic) expansion: Craniocaudal expansion is controlled mechanically โ€” provides predictable force application; balloon expansion is hydraulic and less directional
  • Superior height restoration and kyphosis correction: Preliminary and multicenter studies (Noriega et al, SAKOS study, Spine J 2019) show SpineJack non-inferior to kyphoplasty for pain with superior height restoration
  • 81.5% pain relief at 48 hours in Noriega et al registry study (n=108); 90%+ decrease in analgesia use at 12 months
  • Cost: Most expensive of the three options; requires implant-specific instrumentation
2

Pre-Procedure Checklist

Imaging, labs, implant planning, antibiotics
MRI spine with STIR. Confirm bone marrow edema = active fracture. Assess degree of height loss, fracture morphology, and kyphotic deformity. STIR hyperintensity confirms treatment benefit; no edema in chronic fracture = low response likelihood.
CT spine โ€” mandatory for SpineJack planning. Quantify vertebral height loss (pre-procedure CT: measure anterior, central, and posterior heights). Assess posterior wall integrity. Measure pedicle width to confirm bilateral transpedicular access feasibility. Document kyphotic angle (Cobb angle) for post-procedure comparison. Post-procedure CT used to confirm height restoration and cement distribution.
Select appropriate SpineJack device size. SpineJack is available in a 5-mm diameter implant inserted via a working cannula. Select device length based on vertebral body dimensions from pre-procedure CT. Implant-specific instrumentation required โ€” confirm availability before scheduling.
Labs. INR ≤1.5, platelets ≥50K. CBC, BMP. As an implant procedure: type and screen recommended.
Prophylactic antibiotics โ€” REQUIRED (implant). Cefazolin 1g IV within 60 minutes of incision. Penicillin allergy: clindamycin 600 mg IV or vancomycin 15 mg/kg IV. Repeat dose if procedure >3 hours.
Anesthesia plan. General anesthesia commonly used (implant placement requires precise, controlled patient positioning and longer procedure time vs. vertebroplasty). MAC acceptable for selected patients with good pain tolerance in prone position.
Consent โ€” implant-specific risks. Discuss: device malposition, failure to achieve adequate height restoration, cement leak around device, implant not FDA-approved at all centers (verify regulatory status), infection (implant), adjacent fracture, need for surgical removal if complication (rare).
Multidisciplinary discussion for complex cases. Per published VAD literature โ€” tumor cases, multi-level fractures, or spinal instability warrant multidisciplinary spine team discussion prior to SpineJack placement.
3

Relevant Anatomy

Bilateral access, implant workspace, expansion mechanics

Transpedicular / Parapedicular Access

  • Bilateral approach mandatory: SpineJack requires bilateral implant placement โ€” two cannulae, two devices, simultaneous expansion
  • Standard transpedicular approach (pedicle width ≥4โ€“5 mm); parapedicular approach for narrower pedicles
  • Level range: T5โ€“L5 (VBS system); SpineJack generally applied T4โ€“L5
  • Working cannula (implant-specific trocar) advanced to posterior one-third of vertebral body โ€” confirmed on lateral fluoroscopy

SpineJack Device Anatomy

  • Titanium implant, 5 mm diameter in collapsed state; expands craniocaudally via mechanical compression of the device handle
  • Expansion creates a cavity in the vertebral body within which SpineJack resides โ€” analogous to balloon kyphoplasty cavity but implant remains
  • Mechanical (not hydraulic) expansion = operator-controlled, directional craniocaudal force โ€” compacts trabecular bone vertically
  • PMMA injected through the working cannula simultaneously on both sides, filling the cavity around the in-situ implant
  • Device locked in expanded position before cement injection โ€” ensures height is maintained during cementing

Drill Path & Template

  • After working cannula placed at posterior one-third of vertebral body: inner trocar replaced with guidewire, then bone drill (reamer)
  • Drill advances to desired implant position โ€” terminates just short of the anterior vertebral body cortex
  • Drill removed; template device "cleans" the desired implant site and confirms dimensions
  • Process repeated on contralateral side before any device insertion
  • Both implant expanders inserted through working cannulae, expanded simultaneously under fluoroscopy
4

Technique

Default RadCall approach ยท share your own below
RadCall Standard Default

Supplies

Biplanar fluoroscopy (C-arm) SpineJack implant system (Stryker) โ€” bilateral set Implant-specific working cannulae (5-mm device) Guidewire (implant-specific) Bone drill / reamer Template device (site preparation) SpineJack expander tool (mechanical) Implant-specific PMMA cement 1 mL Luer-lock syringes (cement delivery) Cefazolin 1g IV (antibiotic) ChloraPrep Sterile drapes 1% lidocaine 18G spinal needle (level marking)

Steps โ€” SpineJack Vertebral Augmentation

1

Prophylactic antibiotics & positioning

Administer cefazolin 1g IV within 60 minutes prior to skin incision. Patient prone on radiolucent table. Biplanar fluoroscopy configured. Confirm correct vertebral level with marking needle. Prep and drape widely. Review pre-procedure CT for pedicle dimensions and degree of height loss.
2

Bilateral pedicle entry โ€” working cannulae

Local anesthesia (1% lidocaine) to skin and periosteum bilaterally. Make bilateral stab incisions. Advance implant-specific working cannulae through both pedicles using the "owl eye" technique on AP fluoroscopy. Confirm on lateral: cannula tip should reach the posterior one-third of the vertebral body โ€” not crossing the posterior wall at this stage.
Bilateral pedicular access โ€” SpineJack approach
AP fluoroscopy confirming bilateral pedicular trocar placement for SpineJack procedure
Bilateral pedicular cannulae: same access as kyphoplasty โ€” confirm pedicle wall integrity before advancing; SpineJack requires accurate midline trajectory.
3

Guidewire and bone drill (reamer)

Remove inner trocar from working cannula. Insert implant-specific guidewire. Over the guidewire, advance bone drill (reamer) to desired position. Drill terminates just short of the anterior vertebral body cortex โ€” confirm on lateral fluoroscopy. Drilling creates the channel for the SpineJack implant. Remove drill.
Reamer creating SpineJack cavity
Lateral fluoroscopy showing reamer advancing to create cavity for SpineJack device placement
Reamer advancing to create SpineJack seating cavity โ€” lateral confirms instrument tip position anterior to posterior cortex before device insertion.
4

Template device โ€” site preparation

Insert the template device through the working cannula to "clean" the desired implant site. The template ensures appropriate dimensions and removes loose debris from the drilled channel. Confirm template position under lateral fluoroscopy. Remove template. Repeat steps 3โ€“4 on contralateral side before device insertion.
5

Insert SpineJack expanders bilaterally

Insert SpineJack implant expanders through both working cannulae simultaneously. Confirm position under lateral and AP fluoroscopy โ€” expanders should be in the correct craniocaudal position within the vertebral body. Both devices must be in satisfactory position before expansion begins.
SpineJack expanders โ€” bilateral deployment
Fluoroscopy showing bilateral SpineJack expanders deployed with device deployment tool
Bilateral SpineJack expanders deployed โ€” simultaneous mechanical expansion restores vertebral height; device locks in expanded position before cement injection.
6

Simultaneous mechanical expansion โ€” height restoration

Expand both devices simultaneously using the mechanical expander tool. Expansion is craniocaudal โ€” the device compresses the fracture cleft open, restoring height. Monitor continuously with intermittent fluoroscopy on lateral view. STOP expansion if: end-plate breach visualized, no further height gain despite continued expansion (limit reached), or superior end-plate flattening noted. Goal: restore near-normal vertebral body height.
7

Lock devices in expanded position

Once target height achieved: lock both SpineJack devices in their expanded position using the locking mechanism (per manufacturer instructions). This is a critical step โ€” the device must be locked before cement injection to prevent height recollapse. Remove expander tool; working cannulae and locked devices remain in situ.
8

Simultaneous PMMA cement injection

Mix implant-specific PMMA cement to paste consistency. Inject cement simultaneously on both sides through the working cannulae under continuous biplanar fluoroscopy. Cement fills the cavity created by the SpineJack devices and around the implants. STOP immediately at any sign of posterior leak, foraminal filling, or venous runoff. Standard volumes per level; fill confirmed by AP and lateral fluoroscopy.
9

Cannula removal & final imaging

Once cement polymerizes (1โ€“2 min): remove working cannulae. SpineJack implants remain permanently in situ. Apply pressure at skin entry sites. Post-procedure AP control projection to confirm implant positioning and cement distribution. Post-procedure CT recommended to confirm height restoration, implant position, and exclude canal encroachment.
Post-SpineJack โ€” cement fill and height restoration
Post-procedure fluoroscopy showing SpineJack devices with surrounding PMMA cement and restored vertebral height
Final fluoroscopy: SpineJack devices with surrounding PMMA cement โ€” confirm vertebral height restoration and absence of cement extravasation.

Vertebral Body Stenting (VBS) System โ€” Alternative VAD

  • VBS (DePuy Synthes): Expandable titanium stent deployed using the same balloon as conventional kyphoplasty โ€” stent remains expanded in place after balloon removal (unlike conventional kyphoplasty where only cement remains)
  • Bipedicular approach; suitable for T5โ€“L5 compression fractures
  • After balloon inflation and stent expansion: balloon is removed but stent stays โ€” PMMA injected through same cannula into stent cavity
  • Evidence shows greater vertebral height reduction after VBS vs. standard kyphoplasty (stent holds height after balloon removal)
  • Significant pain reduction and height restoration maintained at 12 months in published series
  • Mechanism: Hydraulic (balloon-based) vs. SpineJack mechanical โ€” both leave permanent implant; different engineering approach
Sign in to view and create community cards
5

Troubleshooting

Problem

Device does not expand / insufficient height gain

Likely cause: Chronic fracture with sclerotic bone, very dense trabecular architecture, or device positioned in wrong location (e.g., in the fracture endplate rather than in trabecular bone).

Next step: Confirm device tip position on lateral fluoroscopy โ€” ensure both implants are within trabecular bone at the same level and aimed at the fracture cleft. Attempt additional expansion force. If maximum expansion reached without adequate height gain: lock device in partially expanded position and proceed with cement. Partial restoration still provides pain relief and structural stabilization.

Problem

Asymmetric expansion โ€” one device advances faster

Likely cause: Asymmetric fracture morphology, one device in denser bone, or slight difference in starting positions.

Next step: Monitor both devices simultaneously on AP fluoroscopy during expansion. Slow the advancing device and apply more force on the lagging side to achieve symmetric height restoration. Small asymmetries are acceptable โ€” do not force symmetric expansion at the cost of superior end-plate breach.

Problem

Cement leak around device

Likely cause: Posterior cortical breach, cement injected at too low viscosity, or fracture line extending to posterior cortex.

Next step: Stop injection immediately. Wait for polymerization at leak site (1โ€“2 min). Resume cautiously if leak self-seals. The SpineJack implant should provide additional containment vs. vertebroplasty โ€” persistent posterior leak despite locked implant suggests unrecognized posterior wall compromise. Post-procedure CT mandatory.

Problem

Superior end-plate breakthrough during expansion

Likely cause: Excessive expansion force, device positioned too cranially, or weakened end-plate from tumor/osteoporosis.

Next step: Stop expansion immediately. Lock device at current position. Assess extent of end-plate disruption on fluoroscopy. Intradiscal cement filling is a risk during subsequent cement injection โ€” monitor carefully and stop if intradiscal filling seen on AP fluoroscopy. Post-procedure CT will characterize extent of end-plate involvement.

6

Complications

Implant-Related Complications

  • Device malposition: Implant too posterior (canal risk) or too anterior (cortical breach) โ€” confirmed on post-procedure CT; surgical removal in rare symptomatic cases
  • Implant migration: Rare with proper technique; risk higher in very osteoporotic bone
  • Infection (deep implant infection): Rare but serious; prophylactic antibiotics mandatory. Requires prolonged antibiotics or explantation if confirmed
  • End-plate disruption: Aggressive expansion may breach end plate; intradiscal cement risk

Cement & Procedure Complications

  • Cement extravasation: Epidural, foraminal, intradiscal, venous/PE โ€” same spectrum as vertebroplasty and kyphoplasty; reduced but not eliminated by implant containment
  • Adjacent vertebral fracture: Stiffened augmented level increases adjacent level stress โ€” counsel patients
  • Failed height restoration: Chronic/sclerotic fractures; partial restoration still provides pain relief
  • Neurologic injury: Rare; from cement epidural leak or device malposition โ€” emergent surgical consult if new deficit

Emergent Escalation Triggers

  • New neurologic deficit post-procedure → emergent spine surgery consult + CT spine
  • Hypoxia / chest pain post-procedure → CT chest angiography (cement PE)
  • Fever + back pain after 48โ€“72h → CBC, CRP, blood cultures; consider implant infection
  • Severe unremitting pain escalation → CT spine (epidural collection or device malposition)
7

Post-Procedure Care

Recovery & Monitoring

  • Recover supine 1โ€“2 hours; complete neurologic exam before discharge
  • Ambulation on post-procedure day 1 โ€” demonstrated in published SpineJack case series
  • Pain score documented at 24โ€“48 hours; expected significant improvement
  • Case series: pain reduction from 6.5/10 pre-procedure to 1/10 post-procedure day 1; kyphotic angle reduced by 11โ€“24 degrees
  • Most patients discharged same day or post-procedure day 1 (institutional preference)

Imaging & Follow-up

  • Post-procedure CT to confirm implant positioning, height restoration, and cement distribution โ€” mandatory for implant procedures
  • Upright weight-bearing AP and lateral X-ray at 1 month to confirm maintained height (key advantage of SpineJack: height durability)
  • Resume anticoagulation: 24 hours post-procedure
  • Osteoporosis management: bisphosphonates, denosumab, or teriparatide โ€” essential to prevent adjacent fractures
  • Physical therapy referral for core strengthening and fall prevention
  • Report fever, new neurologic symptoms, or new acute back pain immediately
8

Critical Pearls

โœฆ
Lock the device BEFORE injecting cement: This is the most critical SpineJack-specific step. Cement injected before locking the device in expanded position will not maintain height โ€” the device could be pushed into a sub-optimal position by injection pressure. Lock both implants, confirm position fluoroscopically, then proceed with cement.
โœฆ
Simultaneous bilateral expansion is essential: Expand both devices at the same time under AP and lateral fluoroscopy. Sequential expansion risks asymmetric height gain and lateral vertebral displacement. The bilateral simultaneous approach creates a symmetric craniocaudal force distribution across the fracture cleft.
โœฆ
Antibiotics are required โ€” not optional: SpineJack is an implant procedure. Cefazolin 1g IV prophylaxis within 60 minutes of incision is mandatory. This differentiates SpineJack from vertebroplasty and balloon kyphoplasty, which do not routinely require antibiotics. Document antibiotic administration in the procedure note.
โœฆ
Drill terminates short of anterior cortex: Over-drilling risks anterior cortical breach with cement leakage anteriorly into the paravertebral soft tissue or, at lumbar levels, into the retroperitoneum. Confirm drill tip position on lateral fluoroscopy โ€” always maintain a 2โ€“3 mm gap from the anterior cortex.
โœฆ
SpineJack advantage over balloon kyphoplasty โ€” implant stays: When a balloon is deflated before cement injection, the trabecular cavity can partially collapse. The SpineJack occupies the cavity permanently โ€” cement fills around a stable implant scaffold. This is the mechanism of superior durable height restoration.
โœฆ
Post-procedure upright X-ray at 1 month: Unlike vertebroplasty, where height gain is minimal and cement is the sole structural element, SpineJack outcomes should be documented with upright weight-bearing radiographs. Height maintenance over time validates implant performance and guides counseling.
!
VADs are "third generation" โ€” require specific training and equipment: SpineJack, VBS, and OsseoFix each have distinct instrumentation, implant-specific trocars, and technique requirements. Do not attempt with vertebroplasty equipment or improvised alternatives. Industry representative proctoring recommended for initial cases at new centers.
9

Related Resources

References, comparison table, related procedures, VAD devices

Vertebral Augmentation Comparison

FeatureVertebroplastyBalloon KyphoplastySpineJack
MechanismDirect cement injectionBalloon inflation creates cavity, then cementTitanium implant expands craniocaudally, then cement
Height restorationMinimalModerate; partial recollapse possibleSuperior โ€” up to 40%; durable (implant permanent)
Cement leak riskHighest (direct injection into cancellous bone)Lower (contained cavity)Low (implant scaffold contains cement)
SedationMAC / LocalMAC / GeneralGeneral / MAC
AntibioticsNot routineNot routineCefazolin 1g IV โ€” required
Implant remainsNoNo (balloon removed)Yes โ€” titanium; permanent
CostLowestModerateHighest
Best forVCF without significant height loss; malignant fractures; low-cost centersFractures with >15% height loss; intact posterior wallSignificant height loss; young patients; durable restoration; tumor cases
Follow-up imagingCT (optional)CT + upright XR at follow-upCT (mandatory) + upright XR at 1 month

Vertebral Augmentation Devices (VADs) Overview

DeviceManufacturerMechanismLevel RangeNotes
SpineJackStryker Corp.Mechanical โ€” craniocaudal expansionT4โ€“L5SAKOS trial (non-inferior to BKP, superior height restoration)
VBS (Vertebral Body Stenting)DePuy SynthesHydraulic (balloon) โ€” stent expands, balloon removedT5โ€“L5Greater height retention than standard BKP after balloon removal
OsseoFixAlphatec SpineMechanical compression of trabecular bone via titanium meshT6โ€“L5Less PMMA required; interlocking bone-titanium effect; absolute CI: retropulsed fragments

Primary Reference

Prologo JD, Ray CE Jr., eds. Advanced Pain Management in Interventional Radiology: A Case-Based Approach. Thieme; 2024. DOI: 10.1055/b000000387
Chapter 18 (Dalili et al โ€” Osteoporotic Fracture III: Vertebral Augmentation Devices)

Additional references: Noriega et al, Spine J 2019 (SAKOS study โ€” SpineJack vs. BKP) · Noriega et al, BioMed Res Int 2015 (108 SpineJack registry, 1-year results) · Vanni et al, J Spine Surg 2016 (third-generation VADs) · Werner et al, J Bone Joint Surg Am 2013 (VBS vs. kyphoplasty RCT) · Disch & Schmoelz, Spine 2014 (VBS augmentation model)